IRCT20160422027520N12已完成未知
Effect of oral nanocurcumin on disease activity, expression levels of microRNA and Th17 cells and Treg cells development factors and serum IL-17, IL-10 level in Behcet patients
Connective Tissue Diseases Research Center0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 60 years（—）
- 性别
- All
入选标准
- •Willingness to cooperate
- •Age range 20 to 60 years
- •Diagnosis of Behcet's disease by rheumatologist
排除标准
- •Use of nutritional supplements and antioxidant and alpha-lipoic acid during a month before the study
- •Pregnancy and lactation
- •History of diabetes and other chronic diseases
- •The history of other autoimmune diseases
- •Admission rate less than 70% of supplemental intake
研究者
相似试验
招募中
3 期
Effect of Curcumin supplement on disease activity in patients with liver cirrhosisiver Cirrhosis.Fibrosis and cirrhosis of liverIRCT20180802040678N1Tabriz University of Medical Sciences70
尚未招募
3 期
Assessment of the effect of nano-curcumin oral intake on clinical signs and serum IL-6 levels in patients with ischemic stroke: Double-blind Clinical TrialIRCT20091108002680N3Rasht University of Medical Sciences40
招募中
2 期
Effect of nanocurcumin in heart failureIRCT20221007056110N1Bagheiat-allah University of Medical Sciences60
已完成
3 期
Effect of curcumin supplementation in patients with lupusSystemic lupus erythematosus.Systemic lupus erythematosus (SLE)M32.9IRCT20210425051077N1Vice Chancellor for Research of Khalkhal University of Medical Sciences66
已完成
2 期
Effect of Nano-Curcumin On Neoadjuvant Chemotherapy of Bladder Cancer PatientsBladder Cancer.Malignant neoplasm of bladderIRCT20180226038875N1Shahid Beheshti University of Medical Sciences24